Clinical Trials Logo
  1. Home
  2. Primary Open Angle Glaucoma
  3. NCT04440527
  4. Details
NCT04440527 Clinical Trial

Intraocular Pressure After Preserflo / Innfocus Microshunt Implantation vs Trabeculectomy

Primary Open Angle Glaucoma Clinical Trial

— PAINT  

Official title:
Intraocular Pressure After Preserflo /Innfocus Microshunt vs Trabeculectomy: a Prospective, Randomised Control-trial (PAINT-Study)

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04440527
Other study ID # PAINT-Study
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 22, 2020
Est. completion date July 22, 2024

Study information
Verified date June 2020
Source Medical University Innsbruck
Contact Teresa Rauchegger, Dr.
Phone +43 512 504 24184
Email teresa.rauchegger@i-med.ac.at
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this project is to compare trabeculectomy with Preserflo / Innfocus Microshunt in patients with Primary Angle Open Glaucoma and Pseudoexfoliation Glaucoma regarding the reduction of intraocular pressure.

Description:

The study is a prospective, randomized, monocentric, part blinded, controlled non-inferiority study of glaucoma patients.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 70
Est. completion date July 22, 2024
Est. primary completion date July 22, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age = 18 years

- Primary open angle glaucoma or pseudoexfoliation glaucoma

- medically uncontrollable intraocular pressure or intolerance of topical therapy

- negative urine/serum pregnancy test of women in childbearing age

- signed and dated informed consent

Exclusion Criteria:

- previous incisional glaucoma procedure on affected eye

- pregnancy, nursing period

- Patients in military service, training periods and civil service

- Participation in another clinical trail

- pre-existing ocular pathologies: high myopia (refraction =8.00 D), thin conjunctiva

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Preserflo / Innfocus Microshunt
The Microshunt features an 8.5-mm tube with an outer diameter of 350 µm and a 70-µm diameter lumen. Implantation creates a subconjunctival bleb and lowers intraocular pressure by increasing aqueous humor outflow.
Other:
• Trabeculectomy
Trabeculectomy is the most commonly performed surgical procedure and is considered the gold standard.

Locations
Country Name City State
Austria Medical University Innsbruck Innsbruck Tyrol

Sponsors (1)
Lead Sponsor Collaborator
Medical University Innsbruck

Country where clinical trial is conducted

Austria, 

Outcome
Type Measure Description Time frame Safety issue
Primary Difference in intraocular pressure The primary endpoint is the difference between intraocular pressure after microshunt implantation vs trabeculectomy. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05564091 - Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma N/A
Recruiting NCT02792803 - A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma Phase 4
Terminated NCT02801617 - Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension Phase 3
Completed NCT01384149 - EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA Phase 1
Completed NCT00300079 - Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension Phase 4
Enrolling by invitation NCT00221923 - African Descent and Glaucoma Evaluation Study
Recruiting NCT05605743 - Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure N/A
Completed NCT04828057 - Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
Completed NCT01442896 - STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk
Enrolling by invitation NCT05557721 - Uddevalla Skövde Transscleral Micropulse Study
Recruiting NCT04595227 - Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device
Terminated NCT04141865 - Effect of Xen Implantation on the Aqueous Humor Proteome
Completed NCT01979913 - An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More Phase 4
Completed NCT01943721 - A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension Phase 1
Completed NCT01769521 - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG N/A
Not yet recruiting NCT01711177 - Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma N/A
Completed NCT02023242 - Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes N/A
Recruiting NCT00773123 - Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma. N/A
Recruiting NCT00773877 - Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients N/A
Completed NCT02544646 - Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG N/A